Riluzole Tablet
Product Images NDC 67877-286

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Riluzole (NDC 67877-286). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Riluzole Blister 50mg 10 Tab

Packaging label for Riluzole Tablet, USP 50 mg by Ascend Laboratories, LLC, showing multiple repeated sections for individual tablets. Each section includes the Rx Only designation, product name and strength, manufacturer details, barcode, and blank fields for lot and expiration dates. The label is designed for a blister pack with an embossing zone indicated.*

FDA Label Image

Riluzole Cart 50 140 Tab

Riluzole Tablets, USP 50 mg oral tablets packaging label from Ascend Laboratories, LLC. The carton contains 140 unit-dose tablets (10 blister packs of 14 tablets each). The label includes dosage instructions, warnings, storage conditions, lot and expiration date fields, and barcode.*

FDA Label Image

Riluzole Cont 50 60 Tab

Label for Riluzole Tablets USP 50 mg by Ascend Laboratories, LLC. The label includes dosage instructions, storage conditions, manufacturer (Alkem Laboratories Ltd., India), and distributor information. It specifies the product contains 60 tablets and is prescription-only (Rx only). Barcodes and a note about UV varnish for part of the label are also visible.*

FDA Label Image

Riluzole-fig-1 (Riluzole Fig 1)

A Kaplan-Meier survival curves chart comparing survival probability over 21 months between Riluzole 50 mg taken twice daily (N=77) and placebo (N=78) groups. The vertical axis shows survival probability, and the horizontal axis shows time in months.*

FDA Label Image

Riluzole-fig-2 (Riluzole Fig 2)

Kaplan-Meier survival curve chart comparing survival probability over months for Riluzole 50 mg twice daily (N=236) versus placebo (N=242). The chart shows survival probabilities on the vertical axis and time in months on the horizontal axis.*

FDA Label Image

Riluzole-st (Riluzole St)

Chemical structure of Riluzole, depicting its molecular arrangement with nitrogen, sulfur, oxygen, and fluorine atoms as part of the molecule associated with the active ingredient in Riluzole tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.